This review explores the complex relationship between cancer and the microbiota, highlighting how microbes can influence cancer susceptibility, progression, and treatment outcomes. The microbiota, particularly the gut microbiota, plays a significant role in cancer development through various mechanisms, including altering host cell proliferation, modulating immune responses, and influencing metabolic processes. Microbial interactions with environmental factors and host genetics contribute to carcinogenesis, and understanding these interactions is crucial for developing new cancer therapies. Microbes can either promote or suppress cancer by affecting the tumor microenvironment. For example, certain bacteria can enhance tumor growth by damaging DNA, promoting inflammation, and modulating signaling pathways such as the Wnt/β-catenin pathway. Conversely, other microbes may help in cancer prevention by maintaining gut homeostasis and reducing inflammation. The microbiota also influences the effectiveness of cancer treatments, including chemotherapy and immunotherapy, by affecting drug metabolism and immune responses. The review discusses the role of specific microbes, such as Fusobacterium nucleatum and Bacteroides fragilis, in promoting cancer progression. These microbes can enhance tumor growth by activating signaling pathways that drive cell proliferation and survival. Additionally, the microbiota can influence the response to immunotherapy by modulating immune cell function and the tumor microenvironment. Advances in sequencing and computational technologies are enabling a deeper understanding of the microbiota's role in cancer. However, challenges remain in translating these findings into clinical applications. The microbiota's potential as a biomarker for cancer diagnosis, prognosis, and treatment response is an area of active research. Future studies aim to elucidate the complex interactions between the microbiota, host genetics, and environmental factors in cancer development and treatment. Overall, the microbiota is emerging as a critical factor in cancer biology, with implications for both diagnosis and therapeutic strategies.This review explores the complex relationship between cancer and the microbiota, highlighting how microbes can influence cancer susceptibility, progression, and treatment outcomes. The microbiota, particularly the gut microbiota, plays a significant role in cancer development through various mechanisms, including altering host cell proliferation, modulating immune responses, and influencing metabolic processes. Microbial interactions with environmental factors and host genetics contribute to carcinogenesis, and understanding these interactions is crucial for developing new cancer therapies. Microbes can either promote or suppress cancer by affecting the tumor microenvironment. For example, certain bacteria can enhance tumor growth by damaging DNA, promoting inflammation, and modulating signaling pathways such as the Wnt/β-catenin pathway. Conversely, other microbes may help in cancer prevention by maintaining gut homeostasis and reducing inflammation. The microbiota also influences the effectiveness of cancer treatments, including chemotherapy and immunotherapy, by affecting drug metabolism and immune responses. The review discusses the role of specific microbes, such as Fusobacterium nucleatum and Bacteroides fragilis, in promoting cancer progression. These microbes can enhance tumor growth by activating signaling pathways that drive cell proliferation and survival. Additionally, the microbiota can influence the response to immunotherapy by modulating immune cell function and the tumor microenvironment. Advances in sequencing and computational technologies are enabling a deeper understanding of the microbiota's role in cancer. However, challenges remain in translating these findings into clinical applications. The microbiota's potential as a biomarker for cancer diagnosis, prognosis, and treatment response is an area of active research. Future studies aim to elucidate the complex interactions between the microbiota, host genetics, and environmental factors in cancer development and treatment. Overall, the microbiota is emerging as a critical factor in cancer biology, with implications for both diagnosis and therapeutic strategies.